BREMAX^®

BREMAX®
(Tulobuterol HCI)

Composition:

Tulobuterol hydrochloride tablet 1 mg Tulobuterol hydrochloride tablet 2 mg Tulobuterol hydrochloride syrup 1 mg/5 ml

Indications:

Prophylaxis and control of bronchospasm in bronchial asthma
Chronic bronchitis
Asthmatic bronchitis
Pulmonary emphysema
Bronchiectasis
Tracheobronchitis with emphysema and other bronchospastic disorders and conditions characterized by bronchoconstriction

How supplied:

Tulobuterol Hydrochloride
1 mg 10x10s tablets
2 mg 10x10s tablets
1 mg/5 ml. 60 ml syrup

MAKING AN EVERLASTING IMPACT ON HUMAN HEALTH FOR 125 YEARS.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

BREMAX^®

BREMAX®
(Tulobuterol HCI)

MAKING AN EVERLASTING IMPACT ON HUMAN HEALTH FOR 125 YEARS.

link01

link01

© 2022 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

ARE YOU A HEALTHCARE PROFESSIONAL?

BREMAX®

BREMAX® (Tulobuterol HCI)

MAKING AN EVERLASTING IMPACT ON HUMAN HEALTH FOR 125 YEARS.

link01

link01

© 2022 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

ARE YOU A HEALTHCARE PROFESSIONAL?

BREMAX^®

BREMAX®
(Tulobuterol HCI)